Rubicon (RBCN) (CREE) (PDS) (EDMC) (OTIV) (HLS) (NKTR) Get New Coverage

Rubicon Technology, Inc. (NASDAQ: RBCN), Cree, Inc. (NASDAQ: CREE), Precision Drilling (NYSE: PDS), Education Management Corp (NASDAQ: EDMC), On Track Innovations Ltd (NASDAQ: OTIV), HealthSouth (NYSE: HLS) and Nektar Therapeutics (NASDAQ: NKTR) getting new analyst coverage.

Ticonderoga initiated coverage on Rubicon Technology, Inc. (RBCN). They placed a “Sell” rating and a price target of $9.00 on the company.

Ticonderoga initiated coverage on Cree, Inc. (CREE). They placed a “Buy” rating and a price target of $39.00 on the company.

Howard Weil initiated coverage on Precision Drilling (PDS). They placed an “Outperform” rating and a price target of $17.00 on the company.

Wunderlich initiated coverage on Education Management Corp. (EDMC). They placed a “Buy” rating and a price target of $20.00 on the company.

Merriman Curhan Ford initiated coverage on On Track Innovations Ltd (OTIV). They placed a “Neutral” rating on the company.

Mizuho initiated coverage on HealthSouth (HLS). They placed a “Buy” rating on the company.

MKM Partners initiated coverage on Nektar Therapeutics (NKTR). They placed a “Buy” rating and a price target of $12.00 on the company.

CNOOC (CEO) (HLS) (PPBI) (SYMC) (AXTI) (AXTI) (LVLT) (REGN) Upgraded

CNOOC (NYSE: CEO), HealthSouth (NYSE: HLS), Pacific Premier Bancorp, Inc. (NASDAQ: PPBI), Symantec (NASDAQ: SYMC), AXT, Inc. (NASDAQ: AXTI), Level 3 (NASDAQ: LVLT) and Regeneron Pharmaceuticals (NASDAQ: REGN) upgraded by analysts.

CNOOC (CEO) was upgraded by UBS AG (NYSE:UBS) from a “Neutral” rating to a “Buy” rating.

HealthSouth (HLS) was upgraded by JMP Securities from a “Market Perform” rating to an “Outperform” rating.

Pacific Premier Bancorp, Inc. (PPBI) was upgraded by Sterne Agee from a “Neutral” rating to a “Buy” rating. They have a price target of $8.70 on the company.

Symantec (SYMC) was upgraded by Wunderlich from a “Hold” rating to a “Buy” rating. They have a price target of $22.00 on the company, up from $21.00.

AXT, Inc. (AXTI) was upgraded by Needham & Company from a “Hold” rating to a “Buy” rating. They have a price target of $11.00 on the company.

Level 3 (LVLT) was upgraded by Raymond James (NYSE:RJF) from an “Underperform” rating to a “Market Perform” rating.

Regeneron Pharmaceuticals (NASDAQ: REGN) was upgraded by RBC Capital from a “Sector Perform” rating to an “Outperform” rating. The have a price target of $70.00 on the company.

Price Targets on (MA) (DOX) (HLS) (LEA) (LO) Raised by Analysts

Amdocs Limited (NYSE: DOX), HealthSouth (NYSE: HLS), Lear Co. (NYSE: LEA), Lorillard Inc. (NYSE: LO) and MasterCard (NYSE: MA) get price targets raised today by analysts.

ThinkEquity raised their price target on Amdocs Limited (DOX) to $32.00. They now have a “hold” rating on the company.

Morgan Stanley (NYSE:MS) raised their price target on HealthSouth (HLS) to $30.00. They have an “overweight” rating on the company.

Goldman Sachs (NYSE:GS) raised their price target on Lear Co. (LEA) to $65.00. They have a “buy” rating on the company.

Goldman Sachs raised their price target on Lorillard Inc. (LO) to $118.00. They now have a “buy” rating on the company.

Goldman Sachs raised their price target on MasterCard (MA) to $310.00. They have a “buy” rating on the company.

Price Targets on (HLS) (HS) (INFN) (MMI) (MSFT) Updated

Price targets on HealthSouth (NYSE: HLS), HealthSpring, Inc (NYSE: HS), Infinera Corp. (NASDAQ: INFN), Motorola Mobility (NYSE: MMI) and Microsoft Corp (NASDAQ: MSFT) get updated.

Morgan Keegan raised their price target on HealthSouth (HLS) from $29.25 to $32.00.

Jefferies (NYSE:JEF) raised their price target on HealthSpring, Inc (HS) from $46.00 to $48.00. They have a “buy” rating on the company.

Citigroup (NYSE:C) cut their price target on Infinera Corp. (INFN) from $9.50 to $9.00.

JPMorgan Chase & Co. (NYSE:JPM) raised their price target on Motorola Mobility (MMI) from $20.00 to $21.00. They have an “underweight” rating on the company.

UBS AG (NYSE:UBS) cut their price target on Microsoft Corp (MSFT) from $35.00 to $32.00. They have a “buy” rating on the company.

Price Targets on (KBR) (LKQX) ( MJN) (HHS) (HLS) Updated

Price targets on KBR, Inc. (NYSE: KBR), LKQ Co. (NASDAQ: LKQX), Mead Johnson Nutrition (NYSE: MJN), Harte-Hanks, Inc. (NYSE: HHS) and HealthSouth (NYSE: HLS) get updated.

Jefferies (NYSE:JEF) raised their price target on KBR, Inc. (KBR) from $33.00 to $42.00. They have a “hold” rating on the company.

Deutsche Bank (NYSE:DB) raised their price target on LKQ Co. (LKQX) from $20.00 to $27.50. They have a “hold” rating on the company.

Deutsche Bank raised their price target on Mead Johnson Nutrition (MJN) from $59.00 to $68.00.

JPMorgan Chase & Co. (NYSE:JPM) cut their price target on Harte-Hanks, Inc. (HHS) from $15.00 to $11.00. They have a “neutral” rating on the company.

Jefferies raised their price target on HealthSouth (HLS) to $30.00.

Price Targets on (HLS) (HS) (INFN) (IP) (NYSE: JNJ) Updated

Price targets on HealthSouth (NYSE: HLS), HealthSpring, Inc (NYSE: HS), Infinera Corp. (NASDAQ: INFN), International Paper Company (NYSE: IP) and Johnson & Johnson (NYSE: JNJ) get updated.

Morgan Keegan raised their price target on HealthSouth (HLS) from $29.25 to $32.00.

Jefferies (NYSE:JEF) raised their price target on HealthSpring, Inc (HS) from $46.00 to $48.00. They have a “buy” rating on the company.

Citigroup (NYSE:C) cut their price target on Infinera Corp. (INFN) from $9.50 to $9.00.

Deutsche Bank (NYSE:DB) raised their price target on International Paper Company (IP) from $35.00 to $39.00. They have a “buy” rating on the company.

UBS AG (NYSE:UBS) raised their price target on Johnson & Johnson (JNJ) from $67.00 to $72.00. They have a “buy” rating on the company.

Price Targets on (HLS) (HS) (INFN) (IP) (JNJ) Updated

Price targets on HealthSouth (NYSE: HLS), HealthSpring, Inc (NYSE: HS), Infinera Corp. (NASDAQ: INFN), International Paper Company (NYSE: IP) and Johnson & Johnson (NYSE: JNJ) were updated today.

Morgan Keegan raised their price target on shares of HealthSouth (HLS) from $29.25 to $32.00.

Jefferies (NYSE:JEF) raised their price target on HealthSpring, Inc (HS) from $46.00 to $48.00. They have a “buy” rating on the company.

Citigroup (NYSE:C) cut their price target on Infinera Corp. (INFN) from $9.50 to $9.00.

Deutsche Bank (NYSE:DB) raised their price target on International Paper Company (IP) from $35.00 to $39.00. They have a “buy” rating on the company.

UBS AG (NYSE:UBS) raised their price target on Johnson & Johnson (JNJ) from $67.00 to $72.00. They have a “buy” rating on the company.

Price Targets on (GPRO) (GWR) (HERO) (HHS) (HLS) Updated

Price targets on Gen-Probe Incorporated (NASDAQ: GPRO), Genesee & Wyoming Inc. (NYSE: GWR), Hercules Offshore, Inc. (NASDAQ: HERO), Harte-Hanks, Inc. (NYSE: HHS) and HealthSouth (NYSE: HLS) were updated today.

Jefferies (NYSE:JEF) raised their price target on Gen-Probe Incorporated (GPRO) from $75.00 to $92.00. They have a “buy” rating on the company.

Jefferies raised their price target on Genesee & Wyoming Inc. (GWR) from $54.00 to $64.00. They have a “neutral” rating on the company.

Global Hunter Securities raised their price target on Hercules Offshore, Inc. (HERO) from $7.00 to $7.50.

JPMorgan Chase & Co. (NYSE:JPM) cut their price target on Harte-Hanks, Inc. (HHS) from $15.00 to $11.00. They have a “neutral” rating on the company.

Jefferies raised their price target on HealthSouth (HLS) to $30.00.

HealthSouth (NYSE:HLS) Surges on Upwardly Revised Earnings Outlook

HealthSouth (NYSE:HLS) closed Monday's trading session up over 10 percent on the increasing of their fourth-quarter earnings outlook

Jefferies (NYSE:JEF) also said that "given the industry's favorable fundamentals, mgmt's proven track record, and the potential for additional near-term deleveraging, we believe shares remain attractively valued."

In response Jefferies increased their full year 2010 and full year 2011 EPS estimates from $1.69 and $1.70 to $1.79 and $1.79 to meet their new outlook.

Jefferies is maintaining their "Buy" rating on HealthSouth, which closed at $23.60, gaining $2.19, or 10.23 percent. Jefferies boosted their price target on them from $24 to $25.